Genetic Signatures (GSS.AX) Stock Price
Genetic Signatures Price
Over the last 14 years Genetic Signatures grew revenue by 34.8% annually, reaching 14.45 M AUD. For Genetic Signatures, the net margin of -96.9% is down versus 8.6% a few years ago.
Genetic Signatures stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Genetic Signatures business model & stock analysis
Frequently asked questions about Genetic Signatures
6 analysts currently rate the Genetic Signatures stock: 5 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the Genetic Signatures share trades at 0.05 EUR (0.08 AUD).
The revenue of Genetic Signatures is 14.45 M AUD. This figure is based on current financial data and reflects the company's business performance.
The profit of Genetic Signatures is -14.01 M AUD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Genetic Signatures is currently -1.22. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Genetic Signatures stock.
The price-to-sales ratio (P/S) of Genetic Signatures is currently 1.18. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Genetic Signatures stock.
The Eulerpool Quality Score for Genetic Signatures is 2/10.
The ISIN of Genetic Signatures is AU000000GSS4. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Genetic Signatures is GSS.AX. The ticker symbol is used to trade Genetic Signatures shares on the stock exchange.
Genetic Signatures stock
Genetic Signatures Peer Group
Genetic Signatures FIGI
All fundamentals and in-depth analysis of Genetic Signatures
Our stock analysis for Genetic Signatures stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Genetic Signatures. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.